rss
Heart 99:1438-1444 doi:10.1136/heartjnl-2013-304073
  • Cardiomyopathy
  • Original article

Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma

  1. Laurence Amar1
  1. 1Hypertension Unit, Université Paris-Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris cedex 15, France
  2. 2Department of Internal Medicine, Università degli Studi di Milano, Ospedale San Giuseppe, Milan, Italy
  3. 3Department of Cardiology, Université Paris-Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris cedex 15, France
  1. Correspondence to Professor Pierre-François Plouin, Hypertension Unit, Université Paris-Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75908 Paris cedex 15, France; pierre-francois.plouin{at}egp.aphp.fr
  • Received 2 April 2013
  • Revised 20 June 2013
  • Accepted 24 June 2013
  • Published Online First 9 July 2013

Abstract

Objective Phaeochromocytomas and paragangliomas (PPGL) can cause acute catecholamine cardiomyopathy (ACC). We assessed the prevalence of ACC and compared the presentation of cases with and without ACC in a large series of PPGL.

Design Single centre retrospective study.

Setting Hypertension Unit, University Hospital, Paris.

Patients 140 consecutive patients with PPGL, referred from January 2003 to September 2012.

Main outcome measures Left ventricular ejection fraction (LVEF), perioperative mortality.

Results Fifteen patients (11%) had suffered an ACC, occurring in 14 cases before the diagnosis of PPGL. Precipitating factors were identified in 11 cases. Twelve patients presented with acute pulmonary oedema, including 10 with cardiogenic shock, requiring life support in eight cases. Seven patients (five with pulmonary oedema) presented with acute chest pain and cardiac dysfunction. Electrocardiographic abnormalities were present in 14 cases: ST segment elevation or pathological Q waves, ST segment depression, and/or diffuse T wave inversion. Six patients displayed classical (apical ballooning) or inverted (basal/mid ventricular stunning) takotsubo-like cardiomyopathy. Coronary arteries were always normal on angiography. In patients with ACC, median LVEF rose from 30% (IQR 23–33%) during ACC to 71% (50–72%) before surgery (n=11, p<0.001). Median LVEF before PPGL surgery was 65% (51–72%) and 65% (60–70%) in patients with and without a history of ACC, respectively (not significant).

Conclusions PPGL may present as ACC in 11% of cases, excluding patients dying from undiagnosed tumours. Left ventricular dysfunction is usually reversible before surgery. PPGL should be suspected in patients with acute heart failure without evidence of valvular or coronary artery disease.